Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Junge

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1996
Cerebral oxygenation changes in response to motor stimulationH Obrig, C Hirth, J G Junge-Hülsing, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1971
Thyreotropin-releasing hormone and serum levels of H-TSH, HGH, thyroxine, insulin and glucoseH Wagner, M Hruhesch, H Vosberg, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
International Immunopharmacology|December 14, 2004
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-upS Jonas, R Neuhaus, G Junge, et al.
Transplantation Proceedings|May 28, 2005
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitisG Junge, R Neuhaus, L Schewior, et al.
Transplantation Proceedings|May 28, 2005
The influence of late acute rejection episodes on long-term graft outcome after liver transplantationG Junge, S G Tullius, V Klitzing, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie|January 1, 1972
[Experimental findings on the site of action and on pharmacodynamics of cytostatic and antiphlogistic drugs in inflammation]H Wagner, G Junge-Hülsing, U S Müller, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approachT Dumortier, M Looby, O Luttringer, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Length of resting period between stimulation cycles modulates hemodynamic response to a motor stimulusH Obrig, C Hirth, J G Junge-Hülsing, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Applied Physiology (Bethesda, Md. : 1985)|September 1, 1996
Cerebral oxygenation changes in response to motor stimulationH Obrig, C Hirth, J G Junge-Hülsing, et al.
Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Metabolisme|March 1, 1971
Thyreotropin-releasing hormone and serum levels of H-TSH, HGH, thyroxine, insulin and glucoseH Wagner, M Hruhesch, H Vosberg, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil reduces calcineurin inhibitor-induced side effects after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
International Immunopharmacology|December 14, 2004
Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-upS Jonas, R Neuhaus, G Junge, et al.
Transplantation Proceedings|May 28, 2005
Withdrawal of steroids: a randomized prospective study of prednisone and tacrolimus versus mycophenolate mofetil and tacrolimus in liver transplant recipients with autoimmune hepatitisG Junge, R Neuhaus, L Schewior, et al.
Transplantation Proceedings|May 28, 2005
The influence of late acute rejection episodes on long-term graft outcome after liver transplantationG Junge, S G Tullius, V Klitzing, et al.
Transplantation Proceedings|November 15, 2002
Mycophenolate mofetil for treatment of ongoing or chronic rejections after liver transplantationR Pfitzmann, J Klupp, J M Langrehr, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Rheumatologie|January 1, 1972
[Experimental findings on the site of action and on pharmacodynamics of cytostatic and antiphlogistic drugs in inflammation]H Wagner, G Junge-Hülsing, U S Müller, et al.
Clinical Pharmacology and Therapeutics|February 12, 2015
Estimating the contribution of everolimus to immunosuppressive efficacy when combined with tacrolimus in liver transplantation: a model-based approachT Dumortier, M Looby, O Luttringer, et al.
Advances in Experimental Medicine and Biology|January 1, 1997
Length of resting period between stimulation cycles modulates hemodynamic response to a motor stimulusH Obrig, C Hirth, J G Junge-Hülsing, et al.
Pageof 7